Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

IL-35 Over-expression is Associated with Genesis of Gastric Cancer

  • Fan, Yong-Gang (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Zhai, Jing-Ming (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Wang, Wei (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Feng, Bing (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Yao, Guo-Liang (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • An, Yan-Hui (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Zeng, Chao (Department of Pathology, Guangdong Medical College)
  • Published : 2015.04.14
Download PDF
⟨ Previous Next ⟩

Abstract

Overexpression of interleukin (IL)-35 has been found in a variety of malignancies, but the expression status in gastric cancer has yet to be elucidated clearly. In the present study, positive expression of EBI3 and p35 was 63.3% and 70.0% of cases, respectively. EBI3 expression was strongly related with larger tumor size and invasion depth (P<0.05). Similarly, expression of p35 was also correlated with larger tumor size (P<0.05). These results indicate that IL-35 might be involved in growth of gastric cancer. Interestingly, EBI3 and p35 expressions were positive correlated with Ki-67 expression. Moreover, EBI3 immunoreactivity was associated with Bcl-2 staining. Our data suggest IL-35 is correlated with genesis of gastric cancer by regulating growth and apoptosis.

Keywords

References

  1. Collison LW, Workman CJ, Kuo TT, et al (2007). The inhibitory cytokine IL- 35 contributes to regulatory T- cell function. Nature, 450, 566-9. https://doi.org/10.1038/nature06306
  2. Collison LW, Chaturvedi V, Henderson AL, et al (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol, 11, 1093-101. https://doi.org/10.1038/ni.1952
  3. Devergne O, Birkenbach M, Kieff E (1997). Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA, 94, 12041-6. https://doi.org/10.1073/pnas.94.22.12041
  4. Huang CH, Loo EX, Kuo IC, et al (2011). Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol, 187, 462-71. https://doi.org/10.4049/jimmunol.1100259
  5. Kochetkova I, Golden S, Holderness K, et al (2010). IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. Immunol, 184, 7144-53. https://doi.org/10.4049/jimmunol.0902739
  6. Larousserie F, Bardel E, Pflanz S, et al (2005). Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol, 166, 1217-28. https://doi.org/10.1016/S0002-9440(10)62340-1
  7. Li X, Mai J, Virtue A, et al (2012). IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines. PLoS One, 7, 33628. https://doi.org/10.1371/journal.pone.0033628
  8. Long J, Zhang X, Wen M, et al (2013). IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun, 430, 364-9. https://doi.org/10.1016/j.bbrc.2012.11.004
  9. Niedobitek G, Pazolt D, Teichmann M, et al (2002). Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol, 198, 310-6. https://doi.org/10.1002/path.1217
  10. Niedbala W, Wei XQ, Cai B, et al (2007). IL-35 is a novel cytokine with therapeutic effects against collagen- induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol, 37, 3021-9. https://doi.org/10.1002/eji.200737810
  11. Nishino R, Takano A, Oshita H, et al (2011). Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res, 17, 6272-86. https://doi.org/10.1158/1078-0432.CCR-11-0060
  12. Pflanz S, Timans JC, Cheung J, et al (2002). IL- 27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 (+) T cells. Immunity, 16, 779-90. https://doi.org/10.1016/S1074-7613(02)00324-2
  13. Poleganov MA, Bachmann M, Pfeilschifter J, et al (2008). Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two kappaB binding sites in the human EBI3 promotor. Mol Immunol, 45, 2869-80. https://doi.org/10.1016/j.molimm.2008.01.021
  14. Schrader JW (2002). Interleukin is as interleukin does. Trends Immunol, 23, 573-4. https://doi.org/10.1016/S1471-4906(02)02336-0
  15. Seyerl M, Kirchberger S, Majdic O, et al (2010). Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol, 40, 321-9. https://doi.org/10.1002/eji.200939527
  16. Wang Z, Liu JQ, Liu Z, et al (2013). Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol, 190, 2415-23. https://doi.org/10.4049/jimmunol.1202535
  17. Whitehead GS, Wilson RH, Nakano K, et al (2012). IL-35 production by inducible costimulator (ICOS)- positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol, 129, 207-15. https://doi.org/10.1016/j.jaci.2011.08.009
  18. Zeng JC1, Zhang Z, Li TY, et al (2013). Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol, 6, 1806-16.

Cited by

  1. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets vol.31, pp.8, 2016, https://doi.org/10.1111/jgh.13342
  2. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease vol.8, pp.1, 2017, https://doi.org/10.1038/s41467-017-00838-4
  3. IL-35 expression is increased in laryngeal squamous cell carcinoma and in the peripheral blood of patients vol.13, pp.5, 2017, https://doi.org/10.3892/ol.2017.5858
  4. IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases vol.143, pp.9, 2018, https://doi.org/10.1002/ijc.31382
  5. IL-35-producing B cells in gastric cancer patients vol.97, pp.19, 2018, https://doi.org/10.1097/MD.0000000000010710
  6. Genetic polymorphism in association with susceptibility to tuberculosis: a study in a Pakistani population pp.1678-4405, 2019, https://doi.org/10.1007/s42770-019-00048-8